ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development
ATCC awarded a one-year, subaward in the amount of $165,962 from NIAID to collaborate on babesiosis and tickborne disease research.
ATCC Receives Grant from NIH to Build New Biomanufacturing Suite at its Manassas Headquarters
ATCC received a C06 Research Facilities Construction Grant from ORIP, part of the NIH, to support the building of ATCC’s new biomanufacturing suite at its headquarters in Manassas, VA.
ATCC Announces Award from NIAID to Support Preclinical Models of Infectious Diseases
ATCC awarded an IDIQ contract by NIAID to support its Division of Microbiology and Infectious Diseases (DMID) in infectious disease treatment and research.
ATCC Receives COF Grant to Apply Toward Its New Biomanufacturing Suite in VA
ATCC received a COF grant administered by the Virginia Economic Development Partnership (VEDP) to apply toward its new biomanufacturing suite at its Manassas headquarters
ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases
ATCC was awarded a task order with a ceiling value of $15.5 million from NIAID to develop well-characterized challenge material (WCCM) for the In Vitro Assessment for Antimicrobial Activity (IVAAA) program.
ATCC Announces Award from the NCI to Provide Biospecimen Processing Services and Assays for Cancer Research
NCI awarded ATCC a five-year contract with a ceiling value of $7.37 million to provide biospecimen processing services and assays for cancer research.
ATCC and Tissue Dynamics Announce Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
ATCC and Tissue Dynamics announced a partnership to develop workflow-friendly cardiac organoid-based kits for improved cardiac safety testing in drug development.
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
ATCC announced a 5-year, $87 million award from BARDA to support the development of next-generation medical countermeasures.